MARK SHEPTOFF FINANCIAL PLANNING, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARK SHEPTOFF FINANCIAL PLANNING, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$26,000
+85.7%
1200.0%0.02%
+87.5%
Q4 2020$14,000
+16.7%
1200.0%0.01%
+14.3%
Q3 2020$12,000
+9.1%
120
+37.9%
0.01%0.0%
Q2 2020$11,000
+37.5%
870.0%0.01%
+16.7%
Q1 2020$8,000
-11.1%
870.0%0.01%0.0%
Q4 2019$9,000
-10.0%
870.0%0.01%
-14.3%
Q3 2019$10,000
-28.6%
87
+8.8%
0.01%
-30.0%
Q2 2019$14,000
+7.7%
800.0%0.01%
+11.1%
Q1 2019$13,000
+62.5%
800.0%0.01%
+28.6%
Q4 2018$8,000
-33.3%
80
+14.3%
0.01%
-12.5%
Q3 2018$12,000
+20.0%
700.0%0.01%
+14.3%
Q2 2018$10,000
+25.0%
700.0%0.01%
+16.7%
Q1 2018$8,000
-11.1%
700.0%0.01%0.0%
Q4 2017$9,000
+28.6%
700.0%0.01%
+20.0%
Q3 2017$7,0000.0%700.0%0.01%0.0%
Q2 2017$7,000
-12.5%
70
-1.4%
0.01%
-16.7%
Q1 2017$8,0000.0%71
+1.4%
0.01%0.0%
Q4 2016$8,000
-11.1%
700.0%0.01%
-14.3%
Q3 2016$9,000
+50.0%
700.0%0.01%
+75.0%
Q2 2016$6,000
+20.0%
700.0%0.00%0.0%
Q1 2016$5,0000.0%700.0%0.00%0.0%
Q4 2015$5,000
-16.7%
700.0%0.00%
-20.0%
Q3 2015$6,000
-33.3%
700.0%0.01%
-28.6%
Q2 2015$9,000
+50.0%
700.0%0.01%
+40.0%
Q1 2015$6,000
-14.3%
70
-30.0%
0.01%
-16.7%
Q4 2014$7,000
-12.5%
1000.0%0.01%
-14.3%
Q3 2014$8,000
-27.3%
1000.0%0.01%
-22.2%
Q2 2014$11,000
+83.3%
1000.0%0.01%
+80.0%
Q1 2014$6,0001000.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders